Royalty Pharma plc (RPRX) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 32.48B USD. 52-week range 35.23 to 64.38 USD. Trailing P/E 29.9. Data as of 2026-10-09.
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of ...